MedPath

Retrospective study to investigate background factors affecting occurrence of nephrotoxicity and recovery from the nephrotoxicity on L-AMB using Electric Medical Data

Not Applicable
Conditions
ephrotoxicity
Registration Number
JPRN-UMIN000032613
Lead Sponsor
agasaki University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
600
Inclusion Criteria

Not provided

Exclusion Criteria

Total L-AMB dose administration of per day for per 1kg of body weight has ever exceeded 6mg (titer) during L-AM administration period

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To investigate background factors affecting occurrence of nephrotoxicity and recovery from the nephrotoxicity on L-AMB.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath